MARKHAM, ON, April 11, 2018 /CNW/ - MedReleaf Corp. (TSX:LEAF)
("MedReleaf" or the "Company"), Canada's first and only ISO 9001 and ICH-GMP
certified cannabis producer, today announced that it has completed
a supply agreement with Société des alcools du Québec ("SAQ") to
supply the future Société québécoise du cannabis (SQDC) with high
quality adult recreational-use cannabis products in accordance with
the previously announced Letter of Intent ("LOI").
Under the terms of the agreement, MedReleaf is committed to
supplying the Quebec market with
8,000 kilograms of cannabis products per year with a minimum
three-year term.
"The adult-use market is rapidly approaching and since signing
our LOI in February we have achieved several milestones to advance
MedReleaf's position as Canada's
leading premium cannabis producer," said Neil Closner, CEO of MedReleaf. "Our recently
announced greenhouse acquisition in Exeter, Ontario brings MedReleaf's fully
funded annual production capacity to 140,000 kilograms of cannabis
products."
As Canada's leading supplier of
premium medical and recreational cannabis, MedReleaf is recognized
for its commitment to cultivating consistent, safe, high-quality
cannabis. At the voter-driven 2017 Lift Canadian Cannabis Awards,
MedReleaf led the industry by winning LP of the year and placing in
10 different categories including first place awards in several
product categories: Top Indica Flower, Top CBD Flower, Top High THC
Flower, and Top High CBD Oil.
The agreement is conditional on the adoption by the federal and
provincial governments of the necessary regulatory framework.
About MedReleaf Corp.
Voted Top Licensed Producer at the 2017 Lift Canadian Cannabis
Awards, MedReleaf is an R&D-driven company dedicated
to innovation, operational excellence and the production of
top-quality cannabis. Sourced from around the world and
carefully cultivated in one of two state of the art ICH-GMP and ISO
9001 certified facilities in Ontario, the Company
delivers a variety of premium products for the global medical
market and is committed to serving the therapeutic needs of its
medical patients and providing a compelling product assortment for
the adult-use recreational consumer.
For more information on MedReleaf, its products, research
and how the company is helping patients #livefree, please visit
MedReleaf.com or follow @medreleaf
SOURCE MedReleaf Corp.